CGTLive’s Weekly Rewind – December 1, 2023

News
Article

Review top news and interview highlights from the week ending December 1, 2023.

CGTLive’s Weekly Rewind – December 1, 2023

CGTLive’s Weekly Rewind – December 1, 2023

Welcome to CGTLive™’s Weekly Rewind! We’ve compiled 5 highlights from this week’s coverage of advances in gene and cell therapies, including FDA actions, notable research, and interviews with experts across the field.

1. FDA to Investigate Risk of T-Cell Malignancy After CAR T-Cell Therapy

The FDA has received reports of multiple T-cell malignancies in patients after approved CAR-T treatment.

2. Marcela Maus, MD, PhD, on New Approaches to CAR T-Cell Therapy for Solid Tumors

The Associate Professor of Medicine at Harvard Medical School discussed upcoming research and strategies to combat present hurdles in the treatment field.

3. Second Gene Therapy for Epidermolysis Bullosa up for Priority Review

Pz-cel has a PDUFA date of May 25, 2024.

4. Fernanda Mesquita, PhD, on Using LAMA2-Exosomes to Improve Cardiomyocyte Survival in Stroke

The research associate at the The Texas Heart Institute discussed preclinical research she presented at AHA’s 2023 Scientific Sessions on MSC-derived exosomes.

5. Autolus Submits Obe-Cel BLA for Adult R/R B-ALL

The company also plans to submit an MAA to the EMA in the first half of 2024.

Newsletter

Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.

Recent Videos
Prerna Mewawalla, MD, medical director of Apheresis and a hematologist-oncologist in the Division of Hematology and Cellular Therapy at Allegheny Health Network, as well as an associate professor at the Drexel University College of Medicine.
Surbhi Sidana, MD, an assistant professor of medicine, bone marrow transplantation, and cellular therapy at Stanford
Alexey Danilov, MD, PhD, the Marianne and Gerhard Pinkus Professor of Early Clinical Therapeutics, medical director of the Early Phase Therapeutics Program for the Systems Clinical Trials Office, codirector of the Toni Stephenson Lymphoma Center, and a professor in the Division of Lymphoma in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope in Duarte, California
© 2025 MJH Life Sciences

All rights reserved.